GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cowealth Medical China Co Ltd (SHSE:603122) » Definitions » EBITDA Margin %

Cowealth Medical China Co (SHSE:603122) EBITDA Margin % : 4.99% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cowealth Medical China Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Cowealth Medical China Co's EBITDA for the three months ended in Mar. 2024 was ¥12 Mil. Cowealth Medical China Co's Revenue for the three months ended in Mar. 2024 was ¥239 Mil. Therefore, Cowealth Medical China Co's EBITDA margin for the quarter that ended in Mar. 2024 was 4.99%.


Cowealth Medical China Co EBITDA Margin % Historical Data

The historical data trend for Cowealth Medical China Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cowealth Medical China Co EBITDA Margin % Chart

Cowealth Medical China Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial 11.22 10.87 10.82 10.14 7.61

Cowealth Medical China Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.52 10.83 8.14 1.05 4.99

Competitive Comparison of Cowealth Medical China Co's EBITDA Margin %

For the Diagnostics & Research subindustry, Cowealth Medical China Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cowealth Medical China Co's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cowealth Medical China Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Cowealth Medical China Co's EBITDA Margin % falls into.



Cowealth Medical China Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Cowealth Medical China Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=83.145/1092.602
=7.61 %

Cowealth Medical China Co's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=11.905/238.622
=4.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cowealth Medical China Co  (SHSE:603122) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Cowealth Medical China Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Cowealth Medical China Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cowealth Medical China Co (SHSE:603122) Business Description

Traded in Other Exchanges
N/A
Address
No. 1001 Qinzhou North Road, 21st Floor, Building 12, Xuhui District, Shanghai, CHN, 200131
Cowealth Medical China Co Ltd operates as a diagnostic clinical laboratory company. It has introduced radiation oncology technology into the market.
Executives
Wang Qiong Zhi Directors, senior managers

Cowealth Medical China Co (SHSE:603122) Headlines

No Headlines